http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007025186-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7c9375b23a8bfcf8286f16a4663a9b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8babc40151e67e9d490c608b22282f9b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15
filingDate 2006-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f042fc03228fd5f200371f7ac152c22
publicationDate 2007-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007025186-A3
titleOfInvention Hydrazone agents to treat cutaneous lesions
abstract A method is disclosed for treating hyperproliferative body surface lesions, including cancerous or precancerous lesion, such as warts or anogenital cancers, by applying a polyaryl mononitro- or dinitrophenylhydrazone such as (I) wherein R1 is hydrogen, hydroxy, 2- or 4-hydroxyphenyl, acetate, nitroso, phosphate, azido, nitrile, amino, dimethylamino, sulfate, methylsulfonate, phosphate, succinate or another water soluble electrophilic group capable of hydrogen bonding; R2 is C6H4OH, C6H4N3, C6H4CN, 4-HO-C6H4-C6H4, C6H4OPO2OH, C6H4OSO2H, C6H4NH2, C6H4NHMe2, C6H4OSO2Me, C6H4OCO(CH2)xCO2H, or C6H5Cl; and X is C6H3-2,4(NO2)2, C6H4-4(NO2), C6H4-3 (NO2), or C6H3-2,4(NO2)2. In a particular example, R1 is OH, R2 is C6H4OH and X is C6H3-2,4(NO2)2.
priorityDate 2005-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9858649-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0187039-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006119284-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004078174-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410072000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455502157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457419056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14574745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11356065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423659
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 43.